These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
230 related items for PubMed ID: 24433744
1. A home telehealth program for patients with severe COPD: the PROMETE study. Segrelles Calvo G, Gómez-Suárez C, Soriano JB, Zamora E, Gónzalez-Gamarra A, González-Béjar M, Jordán A, Tadeo E, Sebastián A, Fernández G, Ancochea J. Respir Med; 2014 Mar; 108(3):453-62. PubMed ID: 24433744 [Abstract] [Full Text] [Related]
10. Hospitalization with acute exacerbation of chronic obstructive pulmonary disease and associated health resource utilization: a population-based Danish cohort study. Johannesdottir SA, Christiansen CF, Johansen MB, Olsen M, Xu X, Parker JM, Molfino NA, Lash TL, Fryzek JP. J Med Econ; 2013 Jul; 16(7):897-906. PubMed ID: 23621504 [Abstract] [Full Text] [Related]
11. Impact of a telehealth and care management program for patients with chronic obstructive pulmonary disease. Au DH, Macaulay DS, Jarvis JL, Desai US, Birnbaum HG. Ann Am Thorac Soc; 2015 Mar; 12(3):323-31. PubMed ID: 25642649 [Abstract] [Full Text] [Related]
13. Frequent hospital readmissions for acute exacerbation of COPD and their associated factors. Cao Z, Ong KC, Eng P, Tan WC, Ng TP. Respirology; 2006 Mar; 11(2):188-95. PubMed ID: 16548905 [Abstract] [Full Text] [Related]
16. A home telemonitoring program reduced exacerbation and healthcare utilization rates in COPD patients with frequent exacerbations. Alrajab S, Smith TR, Owens M, Areno JP, Caldito G. Telemed J E Health; 2012 Dec; 18(10):772-6. PubMed ID: 23082792 [Abstract] [Full Text] [Related]
19. Pulmonary rehabilitation after acute exacerbation of chronic obstructive pulmonary disease in patients who previously completed a pulmonary rehabilitation program. Carr SJ, Hill K, Brooks D, Goldstein RS. J Cardiopulm Rehabil Prev; 2009 Dec; 29(5):318-24. PubMed ID: 19561523 [Abstract] [Full Text] [Related]
20. Efficacy and safety of RPL554, a dual PDE3 and PDE4 inhibitor, in healthy volunteers and in patients with asthma or chronic obstructive pulmonary disease: findings from four clinical trials. Franciosi LG, Diamant Z, Banner KH, Zuiker R, Morelli N, Kamerling IM, de Kam ML, Burggraaf J, Cohen AF, Cazzola M, Calzetta L, Singh D, Spina D, Walker MJ, Page CP. Lancet Respir Med; 2013 Nov; 1(9):714-27. PubMed ID: 24429275 [Abstract] [Full Text] [Related] Page: [Next] [New Search]